Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Phenylalanine Elevations on Metabolic, Cognitive, and Neural Functioning in Adults Heterozygous for Phenylketonuria (PKU)

NCT07220265 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT07220265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Phenylalanine Elevations on Metabolic, Cognitive, and Neural Functioning in Adults Heterozygous for Phenylketonuria (PKU)
Lead sponsor
University of Missouri-Columbia
Phase
Not applicable
Overall status
Recruiting
Start date
December 19, 2025
Completion date
December 31, 2026
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carrier of phenylketonuria, healthy